Latest news
Arm Q1 FY2027 Earnings: Record Revenue and a Guidance Beat, but the Stock Sold Off - TradingKeyTradingKey · Sat, 08 Aug 2026 03:57:27 GMTHalozyme Therapeutics Inc (HALO) (Q2 2026) Earnings Call Highlig - GuruFocusGuruFocus · Sat, 08 Aug 2026 03:12:22 GMTArm (ARM) Q1 2027 Earnings Call Transcript - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 23:58:00 GMTFranco-Nevada Stock Surges 2.16% as Gold Strength and Royalty Portfolio Growth Boost Investor Confidence - kalkine.cakalkine.ca · Fri, 07 Aug 2026 14:13:00 GMTVOX Royalty (NASDAQ:VOXR) Shows High Growth Leadership and Momentum - ChartMillChartMill · Fri, 07 Aug 2026 12:31:48 GMTCitizens raises Halozyme stock price target to $93 on royalty growth - Investing.comInvesting.com · Fri, 07 Aug 2026 12:20:00 GMTLigand Pharmaceuticals Inc (LGND) (Q2 2026) Earnings Call Highlights: Royalty Revenue Surges ... - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 23:18:35 GMTOR Royalties Delivers Strong Q2 Growth and Expands Precious Metals Portfolio - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 21:38:00 GMT